ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT04986423 · RECRUITING
Trial details
- NCT number
- NCT04986423
- Sponsor
- Zenith Epigenetics
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-08
- Primary completion
- 2026-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.